ArticleCancers2025

UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme.

Harry Daniels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.